Skip to main content
Erschienen in: Journal of Neurology 8/2013

01.08.2013 | Original Communication

Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis

verfasst von: Mirja Wallner-Blazek, Alex Rovira, Massimo Fillipp, Mara A. Rocca, David H. Miller, Klaus Schmierer, Jette Frederiksen, Achim Gass, Hugo Gama, Charles P. Tilbery, Antonio J. Rocha, José Flores, Frederik Barkhof, Alexandra Seewann, Jacqueline Palace, Tarek Yousry, Xavier Montalban, Christian Enzinger, Franz Fazekas

Erschienen in: Journal of Neurology | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Atypical lesions of a presumably idiopathic inflammatory demyelinating origin present quite variably and may pose diagnostic problems. The subsequent clinical course is also uncertain. We, therefore, wanted to clarify if atypical idiopathic inflammatory demyelinating lesions (AIIDLs) can be classified according to previously suggested radiologic characteristics and how this classification relates to prognosis. Searching the databases of eight tertiary referral centres we identified 90 adult patients (61 women, 29 men; mean age 34 years) with ≥1 AIIDL. We collected their demographic, clinical and magnetic resonance imaging data and obtained follow-up (FU) information on 77 of these patients over a mean duration of 4 years. The AIIDLs presented as a single lesion in 72 (80 %) patients and exhibited an infiltrative (n = 35), megacystic (n = 16), Baló (n = 10) or ring-like (n = 16) lesion appearance in 77 (86 %) patients. Additional multiple sclerosis (MS)-typical lesions existed in 48 (53 %) patients. During FU, a further clinical attack occurred rarely (23–35 % of patients) except for patients with ring-like AIIDLs (62 %). Further attacks were also significantly more often in patients with coexisting MS-typical lesions (41 vs. 10 %, p < 0.005). New AIIDLs developed in six (7 %), and new MS-typical lesions in 29 (42 %) patients. Our findings confirm the previously reported subtypes of AIIDLs. Most types confer a relatively low risk of further clinical attacks, except for ring-like lesions and the combination with MS-typical lesions.
Literatur
1.
Zurück zum Zitat Polman C, Reingold S, Edan G, Filippi M, Hartung H, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58:840–846PubMedCrossRef Polman C, Reingold S, Edan G, Filippi M, Hartung H, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58:840–846PubMedCrossRef
2.
Zurück zum Zitat Filippi M, Rocca M, Arnold D, Bakshi R, Barkhof F, De Stefano N et al (2006) EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis. Eur J Neurol 13(4):313–325PubMedCrossRef Filippi M, Rocca M, Arnold D, Bakshi R, Barkhof F, De Stefano N et al (2006) EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis. Eur J Neurol 13(4):313–325PubMedCrossRef
3.
Zurück zum Zitat Rovira Cañellas A, Rovira Gols A, Río Izquierdo J, Tintoré Subirana M, Montalban Gairin X (2007) Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology 49(5):393–409PubMedCrossRef Rovira Cañellas A, Rovira Gols A, Río Izquierdo J, Tintoré Subirana M, Montalban Gairin X (2007) Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology 49(5):393–409PubMedCrossRef
4.
Zurück zum Zitat Seewann A, Enzinger C, Filippi M, Barkhof F, Rovira A, Gass A et al (2008) MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: a review of reported findings. J Neurol 255(1):1–10PubMedCrossRef Seewann A, Enzinger C, Filippi M, Barkhof F, Rovira A, Gass A et al (2008) MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: a review of reported findings. J Neurol 255(1):1–10PubMedCrossRef
5.
Zurück zum Zitat Lucchinetti C, Gavrilova R, Metz I, Parisi J, Scheithauer BW, Thomsen K et al (2008) Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 131(pt 7):1759–1775PubMedCrossRef Lucchinetti C, Gavrilova R, Metz I, Parisi J, Scheithauer BW, Thomsen K et al (2008) Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 131(pt 7):1759–1775PubMedCrossRef
6.
Zurück zum Zitat Poser C, Brinar V (2004) The nature of multiple sclerosis. Clin Neurol Neurosurg 106(3):159–171PubMedCrossRef Poser C, Brinar V (2004) The nature of multiple sclerosis. Clin Neurol Neurosurg 106(3):159–171PubMedCrossRef
7.
Zurück zum Zitat Pichiecchio A, Tavazzi E, Maccabelli G, Precupanu CM, Romani A, Roccatagliata L et al (2009) What insights have new imaging techniques given into aggressive forms of MS—different forms of MS or different from MS? Mult Scler 15(3):285–293PubMedCrossRef Pichiecchio A, Tavazzi E, Maccabelli G, Precupanu CM, Romani A, Roccatagliata L et al (2009) What insights have new imaging techniques given into aggressive forms of MS—different forms of MS or different from MS? Mult Scler 15(3):285–293PubMedCrossRef
8.
Zurück zum Zitat Kurtzke J (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMedCrossRef Kurtzke J (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMedCrossRef
9.
Zurück zum Zitat Llufriu S, Pujol T, Blanco Y, Hankiewicz K, Squarcia M, Berenguer J et al (2010) T2 hypointense rims and ring-enhancing lesions in MS. Mult Scler 16(11):1317–1325PubMedCrossRef Llufriu S, Pujol T, Blanco Y, Hankiewicz K, Squarcia M, Berenguer J et al (2010) T2 hypointense rims and ring-enhancing lesions in MS. Mult Scler 16(11):1317–1325PubMedCrossRef
10.
Zurück zum Zitat Montalban X, Tintore M, Swanton J, Barkhof F, Fazekas F, Filippi M et al (2010) MRI criteria for MS in patients with clinically isolated syndromes. Neurology 74(5):427–434PubMedCrossRef Montalban X, Tintore M, Swanton J, Barkhof F, Fazekas F, Filippi M et al (2010) MRI criteria for MS in patients with clinically isolated syndromes. Neurology 74(5):427–434PubMedCrossRef
11.
Zurück zum Zitat Chaodong W, Zhang KN, Wu XM, Gang H, Xie XF, Qu XH et al (2008) Balo’s disease showing benign clinical course and co-existence with multiple sclerosis-like lesions in Chinese. Mult Scler 14(3):418–424CrossRef Chaodong W, Zhang KN, Wu XM, Gang H, Xie XF, Qu XH et al (2008) Balo’s disease showing benign clinical course and co-existence with multiple sclerosis-like lesions in Chinese. Mult Scler 14(3):418–424CrossRef
12.
Zurück zum Zitat Altintas A, Petek B, Isik N, Terzi M, Bolukbasi F, Tavsanli M et al (2012) Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study. Mult Scler 18(10):1448–1453PubMedCrossRef Altintas A, Petek B, Isik N, Terzi M, Bolukbasi F, Tavsanli M et al (2012) Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study. Mult Scler 18(10):1448–1453PubMedCrossRef
13.
Zurück zum Zitat Nagappa M, Taly AB, Sinha S, Bharath RD, Mahadevan A, Bindu PS et al. (2012) Tumefactive demyelination: clinical, imaging and follow-up observations in thirty-nine patients. Acta Neurol Scand [Epub ahead of print] Nagappa M, Taly AB, Sinha S, Bharath RD, Mahadevan A, Bindu PS et al. (2012) Tumefactive demyelination: clinical, imaging and follow-up observations in thirty-nine patients. Acta Neurol Scand [Epub ahead of print]
14.
Zurück zum Zitat Tenembaum S, Chitnis T, Ness J, Hahn JS (2007) Acute disseminated encephalomyelitis. Neurology 68(16 Suppl 2):S23–S36PubMedCrossRef Tenembaum S, Chitnis T, Ness J, Hahn JS (2007) Acute disseminated encephalomyelitis. Neurology 68(16 Suppl 2):S23–S36PubMedCrossRef
15.
Zurück zum Zitat Enzinger C, Strasser-Fuchs S, Ropele S, Kapeller P, Kleinert R, Fazekas F (2005) Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging. Mult Scler 11(2):135–139PubMedCrossRef Enzinger C, Strasser-Fuchs S, Ropele S, Kapeller P, Kleinert R, Fazekas F (2005) Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging. Mult Scler 11(2):135–139PubMedCrossRef
16.
Zurück zum Zitat Cha S, Pierce S, Knopp EA, Johnson G, Yang C, Ton A et al (2001) Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 22(6):1109–1116PubMed Cha S, Pierce S, Knopp EA, Johnson G, Yang C, Ton A et al (2001) Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 22(6):1109–1116PubMed
17.
Zurück zum Zitat Malhotra HS, Jain KK, Agarwal A, Singh MK, Yadav SK, Husain M et al (2009) Characterization of tumefactive demyelinating lesions using MR imaging and in vivo proton MR spectroscopy. Mult Scler 15(2):193–203PubMedCrossRef Malhotra HS, Jain KK, Agarwal A, Singh MK, Yadav SK, Husain M et al (2009) Characterization of tumefactive demyelinating lesions using MR imaging and in vivo proton MR spectroscopy. Mult Scler 15(2):193–203PubMedCrossRef
18.
Zurück zum Zitat Kiriyama T, Kataoka H, Taoka T, Tonomura Y, Terashima M, Morikawa M et al (2011) Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm. J Neuroimaging 21(2):e69–e77PubMedCrossRef Kiriyama T, Kataoka H, Taoka T, Tonomura Y, Terashima M, Morikawa M et al (2011) Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm. J Neuroimaging 21(2):e69–e77PubMedCrossRef
19.
Zurück zum Zitat Saini J, Chatterjee S, Thomas B, Kesavadas C (2011) Conventional and advanced magnetic resonance imaging in tumefactive demyelination. Acta Radiol 52(10):1159–1168PubMedCrossRef Saini J, Chatterjee S, Thomas B, Kesavadas C (2011) Conventional and advanced magnetic resonance imaging in tumefactive demyelination. Acta Radiol 52(10):1159–1168PubMedCrossRef
20.
Zurück zum Zitat Bolcaen J, Acou M, Mertens K, Hallaert G, Van den Broecke C, Achten E et al. (2012) Structural and metabolic features of two different variants of multiple sclerosis: a PET/MRI study. J Neuroimaging [Epub ahead of print] Bolcaen J, Acou M, Mertens K, Hallaert G, Van den Broecke C, Achten E et al. (2012) Structural and metabolic features of two different variants of multiple sclerosis: a PET/MRI study. J Neuroimaging [Epub ahead of print]
Metadaten
Titel
Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis
verfasst von
Mirja Wallner-Blazek
Alex Rovira
Massimo Fillipp
Mara A. Rocca
David H. Miller
Klaus Schmierer
Jette Frederiksen
Achim Gass
Hugo Gama
Charles P. Tilbery
Antonio J. Rocha
José Flores
Frederik Barkhof
Alexandra Seewann
Jacqueline Palace
Tarek Yousry
Xavier Montalban
Christian Enzinger
Franz Fazekas
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 8/2013
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-013-6918-y

Weitere Artikel der Ausgabe 8/2013

Journal of Neurology 8/2013 Zur Ausgabe

Pioneers in Neurology

Haly Abbas (949–982 AD)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.